Peer-reviewedCC BYJAAD case reports
Complete response of refractory tumid lupus to upadacitinib
- 1University of Rochester School of Medicine and Dentistry, Rochester, New York
- 2Department of Dermatology, University of Rochester Medicine, Rochester, New York
Related
- Sustained multisite response to anifrolumab in refractory Chilblain lupus erythematosus.
- Upadacitinib for refractory cutaneous disease in a patient with tif1γ-positive dermatomyositis
- Upadacitinib in refractory acquired reactive perforating collagenosis with atopic dermatitis and chronic kidney disease: a case report.
- Multicentric Reticulohistiocytosis mimicking seronegative rheumatoid arthritis: a case report of destructive erosive arthritis with partial response to Upadacitinib.
- Complete Heart Block in Young Patient With Systemic Lupus Erythematosus: A Case Report.
BibTeX
@article{engels2026complete,
title = {{Complete response of refractory tumid lupus to upadacitinib}},
author = {Ella Engels and Christopher T. Richardson},
journal = {JAAD case reports},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13653988},
note = {CC BY},
}
RIS
TY - JOUR
TI - Complete response of refractory tumid lupus to upadacitinib
AU - Ella Engels
AU - Christopher T. Richardson
PY - 2026
DA - 2026/09/04
JO - JAAD case reports
UR - https://europepmc.org/article/PMC/PMC13653988
SN - 2352-5126
ER -